Please provide at least three factors that affect the price of CLRN.US. Company Performance: CLRN's financial health significantly impacts its stock price. Positive earnings reports, revenue growth, and strong profit margins typically lead to increased investor confidence and a higher stock price. Conversely, losses or disappointing financial results can drive the price down.

Clinical Trial Results: As a clinical-stage biopharmaceutical company, CLRN's stock price is highly sensitive to the outcomes of its clinical trials. Positive data showing efficacy and safety for its drug candidates can cause substantial price increases, while negative or inconclusive results can trigger a sharp decline.

Regulatory Approvals: Approval of CLRN's drug candidates by regulatory agencies like the FDA is a major catalyst for stock price appreciation. These approvals pave the way for commercialization and revenue generation. Delays or rejections in the approval process can negatively affect the stock price.